# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 132

Extent: E+W+S+N.I.

In regulation 165 (omission of regulation 204 (obligation on licensing authority in relation to public announcements))—
(a) in the heading for “Omission” substitute “ Amendment ”;
(b) for “Omit” substitute “ In ”;
(c) after “regulation 204” insert “, in paragraph (1), after “ pharmacovigilance concerns ” insert “ which relate to products authorised under a UKMA(NI) or UKMA(UK) ”.

---
Source: https://www.legislation.gov.uk/uksi/2020/1488/schedule/2/paragraph/132 (the official version)
Page: https://openlegislation.uk/human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-132
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.